Absorbable Nasal Implant Devices Market - By Product Type (Drug Eluting Absorbable Nasal Implants, Non-Drug Eluting Nasal Implants), By Material Type (Polymer, CMC), By End-use (Hospitals, Ambulatory Surgical Centers) & Forecast 2023 - 2032
Global Absorbable Nasal Implant Devices Market size will expand significantly through 2032 High prevalence of nasal disorders in aging people has increased the demand for absorbable nasal implant devices. Moreover, increasing healthcare expenditure across the globe has fostered the development of novel absorbable nasal implant devices, supplementing industry growth. In fact, the industry leaders operating in the space are focusing on product innovations to outshine the competition. Increasing strategic efforts will bring commendable gains to the absorbable nasal implant devices industry over 2023-2032.
The overall market share is classified based on product, material, end-use, and region.
With respect to product, the non-eluting segment will grow at a significant CAGR through 2032. Reduced inflammation with these devices favors their adoption. These implants are typically made from biocompatible materials that are absorbed by the body over time. As the implant absorbs, it reduces the risk of inflammation or foreign body reactions. This can benefit patients prone to excessive scar tissue formation or those with a history of adverse reactions to foreign materials.
Based on material, the market value from the carboxy methyl cellulose (CMC) segment will depict considerable growth through 2032. The versatility and ease of use of these implants support their adoption. These can be used in various nasal procedures, including septoplasty, rhinoplasty, and nasal trauma reconstruction. They can be molded and shaped to fit the specific anatomical requirements of each patient, making them versatile for different surgical applications.
Based on end-use, absorbable nasal implant devices market from the ambulatory surgical centers (ASCs) segment will surge significantly through 2032. ASCs often provide a more personalized and patient-centered experience. The smaller size of these facilities allows for more individualized care and attention. Patients may have more direct access to their surgical team, resulting in higher level of patient satisfaction and comfort. Moreover, the growing number of ambulatory surgical centers is creating lucrative opportunities for segment growth.
From the regional perspective, the Asia Pacific absorbable nasal implant devices market share will grow at a notable CAGR between 2023 and 2032. Growing prevalence of nasal disorders, coupled with the flourishing medical device sector, is generating a plethora of opportunities for regional growth. As per India’s IBEF, in FY22, the export of medical devices from the country was worth USD 2.90 billion and is projected to reach USD 10 billion by 2025.